Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- ViiV Healthcare presents positive, 48-week data from two pivotal phase III studies showing long-acting, injectable two-drug regimen of cabotegravir and rilpivirine has similar efficacy to daily, three-drug oral treatment in adults living with HIV-1 infection
- GSK receives a positive CHMP opinion for intravenous zanamivir for the treatment of complicated influenza
- GSK delivers sales, earnings and cash flow growth in 2018
Tweets from GSK
-
GSK @GSK
If we map the genetics of a disease, could we change its course? #BehindTheScience
about 3 days ago -
GSK @GSK
We're so proud of Anna Xiao, an engineer at our Ware site. She joined other young chemical engineers at the Palace of Westminster to quiz MPs on topical science issues at Voice of the Future 2019. Read more: gsk.to/2Jfqygz twitter.com/IChemE/status/…
about 4 days ago
-
GSK @GSK
How attractive are you to a mosquito? We’re at the #BigBangFair sharing how we’re tackling malaria, a disease that claims over 400,000 lives every year! #bsw19 @BigBangFair
about 5 days ago
